Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

PRLD Prelude Therapeutics Inc

3,85

-0,02 (-0,52%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Prelude Therapeutics (NASDAQ:PRLD)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Prelude Therapeutics Charts.

Prelude Therapeutics (NASDAQ:PRLD)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Prelude Therapeutics Charts.

News Prelude Therapeutics Inc

Form S-3 - Registration statement under Securities Act of 1933
Donnerstag 30 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Donnerstag 16 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 16 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
Donnerstag 9 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Dienstag 7 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Montag 6 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
Dienstag 9 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
Dienstag 5 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Prelude Therapeutics Inc News-Artikel

Strongbow Exploration

Barclays Bank Plc Issuer...

Eib Tf 1,75% Mz29 Usd

Ubs Cio Top Picks Series...

Santan. Perp. A

Monster Beverage

Intesa Sanpaolo

Beijing North Star (PK)

ProShares UltraShort Mat...

Wolf Acquisition

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen